Literature DB >> 2896636

The effect of levocabastine nasal spray in nasal provocation tests.

A G Palma-Carlos1, M L Palma-Carlos, N Rombaut.   

Abstract

The effect of levocabastine, a new specific H1 antagonist, has been investigated against a placebo in nasal provocation tests on 42 allergic patients divided into two parallel groups. The results obtained show that it significantly inhibited the nasal reaction to the allergen and seems to have a long-lasting effect in allergic patients.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 2896636

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Res        ISSN： 0251-1649


  8 in total

Review 1.  Safety and tolerability profiles of intranasal antihistamines and intranasal corticosteroids in the treatment of allergic rhinitis.

Authors:  Rami Jean Salib; Peter Hugo Howarth
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

Review 2.  Allergic eye disease mechanisms.

Authors:  J I McGill; S T Holgate; M K Church; D F Anderson; A Bacon
Journal:  Br J Ophthalmol       Date:  1998-10       Impact factor: 4.638

Review 3.  The antihistamines of the nineties.

Authors:  M M Janssens; P H Howarth
Journal:  Clin Rev Allergy       Date:  1993

Review 4.  Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis.

Authors:  K L Dechant; K L Goa
Journal:  Drugs       Date:  1991-02       Impact factor: 9.546

Review 5.  The pharmacokinetic properties of topical levocabastine. A review.

Authors:  J Heykants; A Van Peer; V Van de Velde; E Snoeck; W Meuldermans; R Woestenborghs
Journal:  Clin Pharmacokinet       Date:  1995-10       Impact factor: 6.447

6.  A review of the tolerability and safety of levocabastine eye drops and nasal spray. Implications for patient management.

Authors:  P H Howarth
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

7.  Topical levocabastine-a review of therapeutic efficacy compared with topical sodium cromoglycate and oral terfenadine on days with high pollen counts.

Authors:  M Azevedo
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711

8.  Treatment of allergic rhinoconjunctivitis: a review of the role of topical levocabastine.

Authors:  R G Wijk
Journal:  Mediators Inflamm       Date:  1995       Impact factor: 4.711
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.